Natural history and treatment decisions in rheumatoid arthritis revisited

Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association
M H Weisman

Abstract

Compliance with RA therapeutic intervention must be viewed within the context of the natural history of the disease with or without drug treatment. Published studies from the 30s to the 80s provide a grim picture: both premature death and marked functional morbidity occur even in population-based analyses. Intervention with drugs appears to have short-term gains with little impact beyond 2 years. The reasons for this apparent paradox are two-fold. (1) our drugs are not as successful as we would like; and (2) clinical trials and long-term outcome studies exaggerate their differences from each other by selection criteria and other methodologic issues. Nevertheless, the picture that is emerging for the 90s is revolutionary. Patients with the worst prognosis are being treated more aggressively earlier in their course, and those that have a favorable prognosis do well without aggressive management and are treated differently. Traditional outcome measures are giving way to others that are more realistic and patient-oriented. The assumption that more (not less) treatment will remedy the situation is being tested. The impact of the success of Methotrexate on this change in philosophy should not be underestimated.

References

Mar 1, 1989·Annals of the Rheumatic Diseases·D L ScottB McConkey
Dec 1, 1988·British Journal of Rheumatology·T D SpectorP L Scott
Jan 1, 1989·Annals of the Rheumatic Diseases·C C ErhardtR N Maini
May 1, 1988·Seminars in Arthritis and Rheumatism·D M van der HeijdeL B van de Putte
Nov 1, 1988·Arthritis and Rheumatism·L F Callahan, T Pincus
Jan 1, 1988·Mayo Clinic Proceedings·S E Gabriel, H S Luthra
Feb 1, 1988·British Journal of Rheumatology·A I Grayzel
Apr 1, 1987·Arthritis and Rheumatism·R S Pinals
May 1, 1987·Arthritis and Rheumatism·E YelinW Epstein
Apr 1, 1986·Arthritis and Rheumatism·Y S SherrerJ F Fries
Jun 1, 1986·Arthritis and Rheumatism·D M MitchellJ F Fries
May 1, 1985·British Journal of Rheumatology·P W ThompsonC G Barnes
Jan 1, 1985·Journal of Chronic Diseases·T Pincus, L F Callahan
Oct 27, 1983·The New England Journal of Medicine·L IannuzziI Kushner
May 1, 1964·Annals of the Rheumatic Diseases·J J DUTHIEA J LAWRIE
Aug 25, 1962·JAMA : the Journal of the American Medical Association·C RAGAN
Jan 29, 1948·The New England Journal of Medicine·C L SHORT, W BAUER

❮ Previous
Next ❯

Citations

Jun 11, 2015·Expert Opinion on Pharmacotherapy·Diederik De CockRené Westhovens
Jan 19, 2007·Alimentary Pharmacology & Therapeutics·S VermeireP Rutgeerts
Feb 6, 2010·Nature Reviews. Gastroenterology & Hepatology·G Van AsschePaul Rutgeerts

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.